95 related articles for article (PubMed ID: 7816938)
1. Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours.
Dubben HH
Radiother Oncol; 1994 Sep; 32(3):197-200. PubMed ID: 7816938
[TBL] [Abstract][Full Text] [Related]
2. [The time factor and time-dose-prescription in the radiotherapy of head and neck tumors].
Dubben HH
Strahlenther Onkol; 1994 Feb; 170(2):101-2. PubMed ID: 8108774
[TBL] [Abstract][Full Text] [Related]
3. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
Withers HR; Taylor JM; Maciejewski B
Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344
[TBL] [Abstract][Full Text] [Related]
4. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.
Dubben HH
Radiother Oncol; 1992 Oct; 25(2):142-3. PubMed ID: 1438933
[No Abstract] [Full Text] [Related]
5. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.
Maciejewski B; Majewski S
Radiother Oncol; 1991 Jul; 21(3):163-70. PubMed ID: 1924851
[TBL] [Abstract][Full Text] [Related]
6. Linear-quadratic analysis of tumour response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts.
Petersen C; Baumann M; Dubben HH; Arps H; Melenkeit A; Helfrich J
Int J Radiat Biol; 1998 Feb; 73(2):197-205. PubMed ID: 9489567
[TBL] [Abstract][Full Text] [Related]
7. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
Kuroda M; Urano M; Nishimura Y; Reynolds R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
Milas L; Nakayama T; Hunter N; Jones S; Lin TM; Yamada S; Thames H; Peters L
Radiother Oncol; 1994 Mar; 30(3):247-53. PubMed ID: 8209009
[TBL] [Abstract][Full Text] [Related]
9. In vivo radiation sensitivity of glioblastoma multiforme.
Taghian A; DuBois W; Budach W; Baumann M; Freeman J; Suit H
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):99-104. PubMed ID: 7721644
[TBL] [Abstract][Full Text] [Related]
10. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data.
Roberts SA; Hendry JH
Radiother Oncol; 1993 Oct; 29(1):69-74. PubMed ID: 8295990
[TBL] [Abstract][Full Text] [Related]
11. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
Pigorsch SU; Wilkens JJ; Kampfer S; Kehl V; Hapfelmeier A; Schläger C; Bier H; Schwaiger M; Combs SE
Radiat Oncol; 2017 Mar; 12(1):45. PubMed ID: 28249612
[TBL] [Abstract][Full Text] [Related]
12. Effect of changing the weekly dose intensity of fractionated irradiation on local control of two human squamous cell carcinomas in nude mice.
Petersen C; Schreiber A; Maiwald C; Arps H; Baumann M
Int J Radiat Biol; 2000 Oct; 76(10):1349-56. PubMed ID: 11057743
[TBL] [Abstract][Full Text] [Related]
13. Residual γH2AX foci predict local tumour control after radiotherapy.
Koch U; Höhne K; von Neubeck C; Thames HD; Yaromina A; Dahm-Daphi J; Baumann M; Krause M
Radiother Oncol; 2013 Sep; 108(3):434-9. PubMed ID: 23891089
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
15. Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.
Wong WW; Mick R; Haraf DJ; Weichselbaum RR; Vokes EE
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):153-62. PubMed ID: 8175423
[TBL] [Abstract][Full Text] [Related]
16. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography.
Johnson CR; Thames HD; Huang DT; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):281-7. PubMed ID: 7673015
[TBL] [Abstract][Full Text] [Related]
17. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy.
Slevin NJ; Hendry JH; Roberts SA; Agren-Cronqvist A
Radiother Oncol; 1992 Aug; 24(4):215-20. PubMed ID: 1410576
[TBL] [Abstract][Full Text] [Related]
18. Elective radiotherapy of the neck in patients with squamous cell carcinoma of the head and neck.
Boysen M; Lövdal O; Söberg R; Jacobsen AB; Tausjö J; Evensen JF
ORL J Otorhinolaryngol Relat Spec; 1992; 54(2):103-7. PubMed ID: 1614684
[TBL] [Abstract][Full Text] [Related]
19. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
20. The explanation for the influence of prescription habits on radiation dose-time parameters for head and neck tumour control.
Hendry JH; Roberts SA; Slevin NJ
Radiother Oncol; 1995 Mar; 34(3):228-9. PubMed ID: 7631029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
